Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies (Q36694734)
scientific article published on March 2004
Language:
(P31) (Q13442814)
(P304) 1133-1137
(P407) (Q1860)
(P433) 6
(P478) 90
(P577) Monday, March 1, 2004
(P921) (Q269829)
(Q128581)
(Q4941552)
(P1433) (Q326309)
(P1476) "Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies" (language: en)
(P2093) J J Body
I J Diel
M Lichinitzer
A Lazarev
M Pecherstorfer
R Bell
D Tripathy
B Bergstrom
(P2860) (Q35208717)
(Q35053969)
(Q34546961)
(Q40593773)
(Q33861716)
(Q34747852)
(Q42283820)
(Q44572717)
(Q44083704)
(Q53544115)
(Q72037799)
(Q74593419)
(Q73504275)
(Q70524877)
(Q62072861)
other details
description scientific article published on March 2004

External Links